Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kura Oncology Reports Data from Tipifarnib Trial in Head and Neck Squamous Cell Carcinoma

americanpharmaceuticalreviewJune 08, 2020

Tag: Kura Oncology , Tipifarnib , HNSCC

PharmaSources Customer Service